# Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars

> **NCT02823236** · PHASE3 · UNKNOWN · sponsor: **Centro Dermatológico Dr. Ladislao de la Pascua** · enrollment: 102 (estimated)

## Conditions studied

- Keloid

## Interventions

- **DRUG:** Topical Pirfenidone
- **DRUG:** Triamcinolone + Pirfenidone
- **DRUG:** Intralesional Triamcinolone

## Key facts

- **NCT ID:** NCT02823236
- **Lead sponsor:** Centro Dermatológico Dr. Ladislao de la Pascua
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10-24
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-05-01
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2017-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02823236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02823236, "Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02823236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*